Adam W Beharry1, Andrew R Judge1. 1. Department of Physical Therapy, 101 S. Newell Drive, P.O. Box 100154, University of Florida, Gainesville, Florida, USA, 32610.
Abstract
INTRODUCTION: Histone deacetylase (HDAC) proteins, which counter the activity of histone acetyltransferases (HATs), are necessary for normal muscle atrophy in response to several pathophysiological conditions. Despite this, it remains unknown whether a common or unique transcriptional profile of HDAC and HAT genes exist during the progression of muscle atrophy. METHODS: Muscles were harvested from cast immobilized, denervated, or nutrient deprived animals for quantitative reverse transcriptase-polymerase chain reaction analysis of HDAC and HAT gene expression. RESULTS: The mRNA levels of Hdac2, Hdac4, Hdac6, Sirt1, p300, Cbp, and Pcaf increased, and Hdac7 decreased in skeletal muscle in each experimental model of muscle atrophy. Hdac1 and Hdac3 were increased only in cast immobilized and denervated muscles. CONCLUSIONS: While specific HDACs and HATs are increased in multiple models of muscle atrophy, increased expression of class I HDACs was unique to muscle disuse, reinforcing that specific HDAC inhibitors may be more effective than pan-HDAC inhibitors at countering muscle atrophy.
INTRODUCTION:Histone deacetylase (HDAC) proteins, which counter the activity of histone acetyltransferases (HATs), are necessary for normal muscle atrophy in response to several pathophysiological conditions. Despite this, it remains unknown whether a common or unique transcriptional profile of HDAC and HAT genes exist during the progression of muscle atrophy. METHODS: Muscles were harvested from cast immobilized, denervated, or nutrient deprived animals for quantitative reverse transcriptase-polymerase chain reaction analysis of HDAC and HAT gene expression. RESULTS: The mRNA levels of Hdac2, Hdac4, Hdac6, Sirt1, p300, Cbp, and Pcaf increased, and Hdac7 decreased in skeletal muscle in each experimental model of muscle atrophy. Hdac1 and Hdac3 were increased only in cast immobilized and denervated muscles. CONCLUSIONS: While specific HDACs and HATs are increased in multiple models of muscle atrophy, increased expression of class I HDACs was unique to muscle disuse, reinforcing that specific HDAC inhibitors may be more effective than pan-HDAC inhibitors at countering muscle atrophy.
Authors: Jennifer M Sacheck; Jon-Philippe K Hyatt; Anna Raffaello; R Thomas Jagoe; Roland R Roy; V Reggie Edgerton; Stewart H Lecker; Alfred L Goldberg Journal: FASEB J Date: 2006-11-20 Impact factor: 5.191
Authors: Dongsheng Cai; J Daniel Frantz; Nicholas E Tawa; Peter A Melendez; Byung-Chul Oh; Hart G W Lidov; Per-Olof Hasselgren; Walter R Frontera; Jongsoon Lee; David J Glass; Steven E Shoelson Journal: Cell Date: 2004-10-15 Impact factor: 41.582
Authors: Christoph Bachmann; Faiza Noreen; Nicol C Voermans; Primo L Schär; John Vissing; Johanna M Fock; Saskia Bulk; Benno Kusters; Steven A Moore; Alan H Beggs; Katherine D Mathews; Megan Meyer; Casie A Genetti; Giovanni Meola; Rosanna Cardani; Emma Mathews; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato; Susan Treves Journal: Hum Mutat Date: 2019-04-01 Impact factor: 4.878
Authors: Ferdinand Von Walden; Matthew Rea; C Brooks Mobley; Yvonne Fondufe-Mittendorf; John J McCarthy; Charlotte A Peterson; Kevin A Murach Journal: Epigenetics Date: 2020-04-28 Impact factor: 4.528
Authors: Marshall B Elam; Gipsy Majumdar; Khyobeni Mozhui; Ivan C Gerling; Santiago R Vera; Hannah Fish-Trotter; Robert W Williams; Richard D Childress; Rajendra Raghow Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240